Vyxeos liposomal

Active substance daunorubicin and cytarabine
Holder Bionical Limited T/A Bionical Emas
Status Running
Indication Newly diagnosed, treatment-related acute myeloid Leukaemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
Public documents Approbation
  Information for the patient
  Informed consent
Last update 28/07/2022

 

Last updated on 28/09/2022